Table 1.
Functions
|
Effects of Klotho depletion
|
Effects of treatment with Klotho
|
Type of cell
|
Ref.
|
Phagocytosis | Reduced | Improved | RPE cells | [41,43] |
Increased expression of Mertk | ||||
VEGF-A | Decreased secretion | RPE cells | [41] | |
Reduced signaling mediated by VEGFR2- and IGF-1R | ||||
Redox balance | Increased oxidative stress | Restored | RPE cells | [41,53] |
Prevention of ROS production | ||||
Increased NRF2 expression and nuclear translocation | ||||
Reduced expression of SOD2 | Restored expression of SOD2 and CAT | |||
Pigmentation | Reduced | RPE cells | [41] | |
Decreased melanin granules | ||||
Mitochondrial function | Reduced biogenesis of mitochondria | Preserved | RPE cells | [53] |
Autophagy | Improved | Retina | [42] | |
Decreased activation of AMPK | ||||
Reduced expression of SIRT1 | ||||
EMT | Decreased expression of mesenchymal cell markers | RPE cells | [66] | |
Apoptosis | Reduced | RPE and retinal endothelial cells | [42,53,54] | |
Increased expression of Bcl-2 | ||||
Decreased expression of Bax | ||||
Decreased activity of Caspase-3 |
VEGF-A: Vascular endothelial growth factor A; IGF-1R: Insulin-like growth factor-1; RPE: Retinal pigment epithelium; ROS: Reactive oxygen species; AMPK: 5' adenosine monophosphate-activated protein kinase; SIRT1: Silent information regulator 1; EMT: Epithelial-mesenchymal transition; NRF2: Nuclear factor E2-related factor 2; SOD2: Superoxide dismutase 2; CAT: Catalase.